Abstract:Background and purpose: Chromobox 3 (CBX3), an important component of chromatin, is involved in the development and progression of various cancers. However, the expression and role of CBX3 in lung adenocarcinoma are still unclear. This study aimed to investigate the relationship between the expression of CBX3 in lung adenocarcinoma and prognosis of lung adenocarcinoma, and to study the effects of CBX3 on proliferation, migration and invasion of A549 lung adenocarcinoma cells. Methods: Transcriptome data of lung adenocarcinoma and corresponding clinical data were downloaded from the Cancer Genome Atlas (TCGA), and R software was used to analyze the expression difference of CBX3 and the correlation of immune infiltration in lung adenocarcinoma. The prognostic significance of CBX3 in lung adenocarcinoma was analyzed by receiver operating characteristic (ROC) curve and Kaplan-Meier analysis. Twenty lung adenocarcinoma samples from patients (with informed consent obtained) who underwent palliative or radical lung cancer resection from August 2020 to January 2021 were collected from the intelligent Biobank of Peking University Shenzhen Hospital at -80 ℃. Real-time fluorescent quantitative polymerase chain reaction (RTFQ-PCR) was used to verify the expression of CBX3 in 20 frozen lung adenocarcinoma tissue samples and paired normal lung tissues. A549 cells were transfected with small interfering RNA (siRNA) to silence the expression of CBX3, and A549 cells were divided into silent group (si-CBX3 group) and negative control group (si-NC group) according to the type of siRNA transfection. The effects of CBX3 on proliferation, migration and invasion of A549 cells were investigated by cell counting kit-8 (CCK-8) assay, clone formation assay, scratch assay and transwell assay, respectively. Results: The difference analysis based on TCGA lung adenocarcinoma data and RTFQ-PCR results of lung adenocarcinoma samples showed that CBX3 was significantly overexpressed in lung adenocarcinoma (P<0.05). The infiltration of T helper 2 (Th2) cells was positively correlated with the expression of CBX3 [correlation coefficient (r)=0.437], while mast cells (r=-0.444), eosinophils (r=-0.380) and other immune cells were negatively correlated with the expression of CBX3. The area under ROC curve (AUC) value was 0.912, indicating that CBX3 has a good diagnostic value for lung adenocarcinoma. Kaplan-Meier analysis showed that the survival period of the group with high expression of CBX3 was shorter, suggesting a poor prognosis. After the expression of CBX3 was silenced in A549 cells, significantly decreased proliferation ability of A549 cells was detected by CCK-8 and clone formation assays (P<0.01). The results of scratch assay showed that the mobility of A549 cells was (22.68±3.44)% after silencing, which was significantly lower compared with the control group (P<0.05). Transwell assay results showed that the relative invasion rate of A549 cells was (53.94±5.39)%, and the invasion ability was significantly decreased (P<0.01). Conclusion: CBX3 is significantly overexpressed in lung adenocarcinoma, which predicts poor prognosis of lung adenocarcinoma and can be used as a prognostic marker of lung adenocarcinoma, and the high expression of CBX3 promotes the proliferation, migration and invasion of A549 cells.

CBX3 is a Prognostic Biomarker Correlated with ATR Activation and Immune Infiltration in Head and Neck Squamous Cell Carcinoma

HtrA3: a Promising Prognostic Biomarker and Therapeutic Target for Head and Neck Squamous Cell Carcinoma

CBX3 Is a Prognostic Biomarker That Is Correlated With Lymphocyte Infiltration in Hepatocellular Carcinoma

CBX3 Promotes Tumor Proliferation by Regulating G1/S Phase Via P21 Downregulation and Associates with Poor Prognosis in Tongue Squamous Cell Carcinoma.

Diverse CBX family members as potential prognostic biomarkers in non-small-cell lung cancer

CBX3 promotes breast cancer progression and high level of CBX3 predicts poor prognosis in patients

Expression, Prognostic Value of CBX3 in Lung Adenocarcinoma and Its Effect on Biological Behavior of Cancer Cells

Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma

Expression and Prognostic Value of Chromobox Family Proteins in Esophageal Cancer

PBX3 is Associated with Proliferation and Poor Prognosis in Patients with Cervical Cancer.

CBXs-related Prognostic Gene Signature Correlates with Immune Microenvironment in Gastric Cancer

Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma

CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses

Comprehensive Analysis of Prognostic Value and Immune Infiltration of Chromobox Family Members in Colorectal Cancer

Clinicopathological significance of CBX3 in colorectal cancer: An intensive expression study based on formalin-fixed and paraffin-embedded tissues

Uncovering the role of aquaporin and chromobox family members as potential biomarkers in head and neck squamous cell carcinoma via integrative multiomics and in silico approach

Members of the Chromobox Family Have Prognostic Value in Hepatocellular Carcinoma.

CXC ligand 13 orchestrates an immunoactive microenvironment and enhances immunotherapy response in head and neck squamous cell carcinoma

IKZF3 is a novel prognostic biomarker for head and neck squamous cell carcinoma: A study based on bioinformatics analysis

Bioinformatic Analysis of Prognostic Value and Immune Cell Infiltration of Chromobox Family Proteins in Esophageal Cancer

CBX3/HP1γ is Upregulated in Tongue Squamous Cell Carcinoma and is Associated with an Unfavorable Prognosis